{"disease":{"id":"blasts-under-30-percent-of-bone-marrow-nucleated-cells","name":"blasts under 30 percent of bone marrow nucleated cells"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02906696","title":"Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}